Severe Fredrickson Type V Hypertriglyceridemia

Drug	Drug Name	Drug Description
DB01039	Fenofibrate	A peroxisome proliferator receptor alpha activator used to lower LDL-C, total-C, triglycerides, and Apo B, while increasing HDL-C in hypercholesterolemia, dyslipidemia, and hypertriglyceridemia.

Drug	Drug Name	Target	Type
DB01039	Fenofibrate	Peroxisome proliferator-activated receptor alpha	target
DB01039	Fenofibrate	Matrix metalloproteinase-25	target
DB01039	Fenofibrate	Cytochrome P450 2C8	enzyme
DB01039	Fenofibrate	Cytochrome P450 2C9	enzyme
DB01039	Fenofibrate	Nuclear receptor subfamily 1 group I member 2	target
DB01039	Fenofibrate	UDP-glucuronosyltransferase 1-9	enzyme
DB01039	Fenofibrate	Bile salt export pump	transporter
DB01039	Fenofibrate	Serum albumin	carrier
DB01039	Fenofibrate	Cytochrome P450 2C19	enzyme
DB01039	Fenofibrate	Cytochrome P450 2A6	enzyme
DB01039	Fenofibrate	Liver carboxylesterase 1	enzyme
DB01039	Fenofibrate	Carbonyl reductase [NADPH] 1	enzyme
DB01039	Fenofibrate	Aldo-keto reductase family 1 member C1	enzyme
DB01039	Fenofibrate	Aldo-keto reductase family 1 member C2	enzyme
DB01039	Fenofibrate	Aldo-keto reductase family 1 member C3	enzyme
DB01039	Fenofibrate	Aldose reductase	enzyme

Drug	Drug Name	Phase	Status	Count